Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 863669324 | 8636693 | 24 | F | 20160201 | 20160923 | 20120626 | 20160930 | EXP | PHHY2012CA045207 | SANDOZ | 74.92 | YR | M | Y | 0.00000 | 20161001 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 863669324 | 8636693 | 1 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | UNK, ONCE/SINGLE (TEST DOSE) | D | 0 | 1X | ||||||||
| 863669324 | 8636693 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO | U | 0 | 20 | MG | SUSPENSION | /month | |||||
| 863669324 | 8636693 | 3 | PS | METOPROLOL. | METOPROLOL | 1 | Unknown | UNK | U | 73288 | |||||||||
| 863669324 | 8636693 | 4 | C | NITRO-DUR | NITROGLYCERIN | 1 | Unknown | 0.8 MG, Q12H | U | 0 | .8 | MG | Q12H | ||||||
| 863669324 | 8636693 | 5 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | Unknown | 60 MG, QD | U | 0 | 60 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 863669324 | 8636693 | 1 | Angiodysplasia |
| 863669324 | 8636693 | 2 | Angiodysplasia |
| 863669324 | 8636693 | 3 | Angiodysplasia |
| 863669324 | 8636693 | 4 | Product used for unknown indication |
| 863669324 | 8636693 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 863669324 | 8636693 | HO |
| 863669324 | 8636693 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 863669324 | 8636693 | Angina pectoris | |
| 863669324 | 8636693 | Blood pressure abnormal | |
| 863669324 | 8636693 | Blood pressure diastolic decreased | |
| 863669324 | 8636693 | Blood pressure systolic increased | |
| 863669324 | 8636693 | Body temperature decreased | |
| 863669324 | 8636693 | Faeces discoloured | |
| 863669324 | 8636693 | Fatigue | |
| 863669324 | 8636693 | Haemoglobin decreased | |
| 863669324 | 8636693 | Heart rate decreased | |
| 863669324 | 8636693 | Hypersomnia | |
| 863669324 | 8636693 | Hypoaesthesia | |
| 863669324 | 8636693 | Injection site pain | |
| 863669324 | 8636693 | Muscle spasms | |
| 863669324 | 8636693 | Pain in extremity | |
| 863669324 | 8636693 | Product use issue | |
| 863669324 | 8636693 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 863669324 | 8636693 | 1 | 20120322 | 20120322 | 0 | |
| 863669324 | 8636693 | 2 | 20120329 | 0 |